Expect Integrase Inhibitors to Gain an Edge in Treating HIV

October 2018

Updated guidelines will lead to a shift in preferred antiretroviral meds for treating HIV in adults.

Expect more patients to start regimens with integrase inhibitors...especially bictegravir (Biktarvy) or dolutegravir (Tivicay, etc).

That's because integrase inhibitors are often better tolerated than protease inhibitors, such as Prezista...or NON-nucleoside reverse transcriptase inhibitors (NNRTIs), such as Sustiva.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote